Morgan Stanley Sees Factors That Could Spark Investor Interest in Baxter International

In a report published Monday, Morgan Stanley analyst David R. Lewis reiterated an Equal-Weight rating on Baxter International BAX. In the report, Morgan Stanley noted, “Baxter is the most keenly debated stock in large cap devices. Recent meetings with management did little to mute our near-term concerns into a difficult ‘14/15 but path to value creation may emerge in 2H14. Successful 855 Phase III data and HyQ approval could spark investor interest next year.” Baxter International closed on Friday at $66.27.